Product Information

COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $3944.2083 per ML under NDC 00078063941. Its NADAC has been published 488 times since Jul 19, 2017.

COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)

secukinumab
$3944.2083per ML

Strength

150 mg/mL

NDC

00078063941

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

SECUKINUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125504

On Market Since

1/21/2015

Pharmacological Classes

Interleukin-17A Antagonist
Interleukin-17A Antagonists

Price Statistics

The NADAC for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) has been published 488 times since Jul 19, 2017, and over the history we have for it it has risen 87.2%. The table below summarizes its recorded NADAC range and movement.

Current price$3944.2083 per ML
All-time high$3976.8992 (Jun 10, 2026)
All-time low$2106.4112 (Jul 19, 2017)
52-week high$3976.8992
52-week low$3692.3110
Median price$3055.0973
Average price$3044.1629
Largest weekly change+9.9% (Jan 23, 2019)
Weeks tracked488
Tracking sinceJul 19, 2017

Price History

1W

-0.0%

1M

-0.1%

3M

+0.1%

6M

-0.8%

1Y

+6.8%

3Y

+17.6%

5Y

+39.0%

All

+87.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?

The current National Average Drug Acquisition Cost (NADAC) for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN), manufactured by Novartis Pharmaceuticals Corporation, is $3944.2083 per ML (NDC 00078063941), effective Nov 18, 2026.

How has the price of COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) changed over time?

Over the history we have for it, the NADAC for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) has risen 87.2%. It has been tracked across 488 weekly CMS publications since Jul 19, 2017.

What are the highest and lowest recorded NADAC prices for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?

Since Jul 19, 2017, the NADAC for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) has ranged from a low of $2106.4112 (Jul 19, 2017) to a high of $3976.8992 (Jun 10, 2026), with a median of $3055.0973 per ML.

Are there cheaper alternatives to COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES, is $3934.1368 per ML — about 0% below COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN).

Who manufactures COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?

COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) (NDC 00078063941) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.